USFDA-GUIDELINEBASED VALIDATION OF TESTING METHODFOR RIFAMPICIN IN INDONESIANSERUM SPECIMEN
ABSTRACT Regarding a new regulation from Indonesia FDA (Badan POM-RI), all new non patent drugs should show bioequivalence with the originator drug prior to registration. Bioequivalence testing (BE-testing)has to be performed to the people that represented of population to which the drug to be admin...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article NonPeerReviewed |
| Published: |
[Yogyakarta] : Universitas Gadjah Mada
2010
|
| Subjects: | |
| Online Access: | https://repository.ugm.ac.id/28070/ http://i-lib.ugm.ac.id/jurnal/download.php?dataId=11133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Gadjah Mada |